No Data
Poinsettia: Report for the first quarter of 2025
Poinsettia: 2024 Annual Report Summary
Poinsettia: Annual Report 2024
There's Reason For Concern Over ApicHope Pharmaceutical Group Co., Ltd.'s (SZSE:300723) Massive 45% Price Jump
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.
Even Though ApicHope Pharmaceutical Group (SZSE:300723) Has Lost CN¥660m Market Cap in Last 7 Days, Shareholders Are Still up 47% Over 5 Years
Do ApicHope Pharmaceutical's (SZSE:300723) Earnings Warrant Your Attention?
